Imagine surviving a major stroke and the procedure to clear the clot, only to see your condition worsen in the next 24 hours. This frightening scenario, called early neurological deterioration (END), happened to about 30% of patients in a new study. That's 208 out of 682 people who had undergone endovascular treatment, a procedure to physically remove a stroke-causing clot. The research looked back at these cases to see if there were clues about who was most vulnerable. The key finding was that the size of the initial brain injury, known as infarct volume, stood out. A larger volume of damaged brain tissue was linked to a higher risk of getting worse, especially if the worsening was due to bleeding in the brain. The study's method—looking at past records—means it can only show an association, not prove that the brain injury size causes the decline. It's a strong signal for doctors to pay attention to, suggesting that checking this measurement after the procedure could help identify patients who need extra-close monitoring. More research is needed to confirm if using this information can actually lead to better outcomes.
Infarct volume predicts early neurological deterioration after endovascular stroke treatmentCan a brain scan after stroke treatment predict who might get worse?
AI-generated summary of the cited source, checked by automated accuracy review. How we work
A retrospective cohort study analyzed 682 ischemic stroke patients who underwent endovascular treatment (EVT) to examine predictors of early neurological deterioration (END), defined as a National Institutes of Health Stroke Scale (NIHSS) increase of ≥4 points within 24 hours post-procedure. The study did not report a comparator group, specific setting, or detailed patient characteristics beyond the procedure and outcome definition. The primary finding was that 208 patients (30.5%) developed END. Infarct volume was identified as an independent predictor for overall END, with an area under the curve (AUC) of 0.768. For the secondary outcomes, infarct volume showed predictive value for non-hemorrhagic END (AUC = 0.682) and particularly strong predictive value for hemorrhagic END (AUC = 0.825). An optimal infarct volume threshold of 35.5 mL was reported for predicting END. Safety and tolerability data were not reported. The key limitation is the retrospective study design, which can introduce bias and limits causal inference. The funding source and potential conflicts of interest were not reported. The practice relevance is restrained; the findings suggest an association where incorporating infarct volume into postoperative assessment may help flag patients at higher risk for deterioration, but this requires prospective validation.